$244.23
0.32%
NYSE, Mon, Nov 25 2024
ISIN
US03073E1055
Symbol
ABC

Cencora Stock price

$244.23
+9.76 4.16% 1M
+25.34 11.58% 6M
+38.85 18.92% YTD
+42.45 21.04% 1Y
+120.79 97.85% 3Y
+153.59 169.45% 5Y
+153.91 170.41% 10Y
NYSE, Closing price Mon, Nov 25 2024
-0.79 0.32%
ISIN
US03073E1055
Symbol
ABC
Sector

Key metrics

Market capitalization $48.12b
Enterprise Value $49.38b
P/E (TTM) P/E ratio 32.53
EV/FCF (TTM) EV/FCF 16.47
EV/Sales (TTM) EV/Sales 0.17
P/S ratio (TTM) P/S ratio 0.16
P/B ratio (TTM) P/B ratio 52.00
Dividend yield 0.84%
Last dividend (FY24) $2.04
Revenue growth (TTM) Revenue growth 12.12%
Revenue (TTM) Revenue $293.96b
EBIT (operating result TTM) EBIT $3.05b
Free Cash Flow (TTM) Free Cash Flow $3.00b
Cash position $3.13b
EPS (TTM) EPS $7.51
P/E forward 18.48
P/S forward 0.15
EV/Sales forward 0.16
Short interest 4.37%
Show more

Is Cencora a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Cencora Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Cencora forecast:

11x Buy
55%
9x Hold
45%

Analyst Opinions

20 Analysts have issued a Cencora forecast:

Buy
55%
Hold
45%

Financial data from Cencora

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
293,959 293,959
12% 12%
100%
- Direct Costs 285,249 285,249
12% 12%
97%
8,709 8,709
12% 12%
3%
- Selling and Administrative Expenses 4,551 4,551
5% 5%
2%
- Research and Development Expense - -
-
-
4,159 4,159
22% 22%
1%
- Depreciation and Amortization 1,111 1,111
15% 15%
0%
EBIT (Operating Income) EBIT 3,048 3,048
25% 25%
1%
Net Profit 1,509 1,509
14% 14%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cencora directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Head office United States
CEO Robert Mauch
Founded 1947
Website www.cencora.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today